Hester Biosciences Ltd

Hester Biosciences is engaged in manufacturing of Poultry vaccines and Large Animal Vaccines and trading of Poultry and Large animal health products.(Source : 201903 Annual Report Page No: 86)

  • Market Cap: 1,366 Cr.
  • Current Price: 1,605
  • 52 weeks High / Low 2048.00 / 1033.50
  • Book Value: 217.01
  • Stock P/E: 33.42
  • Dividend Yield: 0.69 %
  • ROCE: 26.65 %
  • ROE: 26.16 %
  • Sales Growth (3Yrs): 21.00 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 10.00
Pros:
Company has good consistent profit growth of 34.51% over 5 years
Company has been maintaining a healthy dividend payout of 24.96%
Cons:
Stock is trading at 7.40 times its book value
Promoter holding has decreased by -0.36% over last quarter

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
40 43 43 52 45 44
25 27 23 35 27 33
Operating Profit 15 15 20 17 18 11
OPM % 37% 36% 47% 33% 39% 25%
Other Income 1 0 0 6 1 1
Interest 1 2 1 2 2 1
Depreciation 2 3 2 4 3 3
Profit before tax 12 10 17 17 13 7
Tax % 31% 44% 26% 20% 38% 13%
Net Profit 9 7 16 10 8 7
EPS in Rs 9.75 6.93 19.00 15.87 9.51 7.30
Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
42 48 65 69 90 101 123 136 178 184
24 30 43 44 64 67 82 89 110 118
Operating Profit 18 19 22 24 25 34 41 47 68 67
OPM % 43% 39% 34% 36% 28% 34% 33% 35% 38% 36%
Other Income 0 0 0 1 3 1 0 3 7 7
Interest 3 3 3 6 5 4 4 4 7 6
Depreciation 4 4 4 5 6 6 7 10 12 13
Profit before tax 11 12 14 13 18 25 31 36 57 55
Tax % 32% 37% 37% 31% 26% 23% 26% 36% 28%
Net Profit 8 8 9 9 14 19 24 26 42 41
EPS in Rs 8.85 10.54 10.77 15.35 21.73 27.68 30.12 48.86 51.68
Dividend Payout % 24% 7% 18% 18% 19% 18% 19% 33% 23%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:20.99%
3 Years:21.00%
TTM:30.99%
Compounded Profit Growth
10 Years:%
5 Years:34.51%
3 Years:29.03%
TTM:62.60%
Stock Price CAGR
10 Years:36.89%
5 Years:34.86%
3 Years:27.97%
1 Year:44.74%
Return on Equity
10 Years:%
5 Years:21.16%
3 Years:22.58%
Last Year:26.16%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Sep 2019
5 6 9 9 9 9 9 9 9 9
Reserves 41 54 59 66 76 93 113 132 169 176
Borrowings 21 16 32 48 55 59 66 69 90 95
15 19 24 19 20 25 30 37 32 69
Total Liabilities 82 95 124 142 161 186 218 246 299 349
39 39 38 54 60 65 102 110 145 142
CWIP 0 6 29 21 33 36 21 32 7 39
Investments 0 0 0 0 0 0 0 0 0 0
43 50 57 68 68 85 94 104 148 168
Total Assets 82 95 124 142 161 186 218 246 299 349

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
5 14 12 9 20 19 35 38 48
-4 -10 -23 -15 -21 -13 -30 -26 -23
-1 -2 10 7 7 -7 2 -11 3
Net Cash Flow 1 2 -1 2 5 -1 6 1 28

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 20% 20% 18% 15% 19% 20% 20% 27%
Debtor Days 115 109 85 75 72 95 79 87 65
Inventory Turnover 1.92 2.21 2.06 2.77 3.20 3.67 3.72 3.93

Recent Announcements

View all announcements

Annual Reports

Credit Ratings